Cargando…
Genetic and epigenetic regulation of Catechol-O-methyltransferase in relation to inflammation in chronic fatigue syndrome and Fibromyalgia
BACKGROUND: Catechol-O-methyltransferase (COMT) has been shown to influence clinical pain, descending modulation, and exercise-induced symptom worsening. COMT regulates nociceptive processing and inflammation, key pathophysiological features of Chronic Fatigue Syndrome and Fibromyalgia (CFS/FM). We...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9598022/ https://www.ncbi.nlm.nih.gov/pubmed/36284330 http://dx.doi.org/10.1186/s12967-022-03662-7 |
_version_ | 1784816229233459200 |
---|---|
author | Polli, Andrea Hendrix, Jolien Ickmans, Kelly Bakusic, Jelena Ghosh, Manosij Monteyne, Dora Velkeniers, Brigitte Bekaert, Bram Nijs, Jo Godderis, Lode |
author_facet | Polli, Andrea Hendrix, Jolien Ickmans, Kelly Bakusic, Jelena Ghosh, Manosij Monteyne, Dora Velkeniers, Brigitte Bekaert, Bram Nijs, Jo Godderis, Lode |
author_sort | Polli, Andrea |
collection | PubMed |
description | BACKGROUND: Catechol-O-methyltransferase (COMT) has been shown to influence clinical pain, descending modulation, and exercise-induced symptom worsening. COMT regulates nociceptive processing and inflammation, key pathophysiological features of Chronic Fatigue Syndrome and Fibromyalgia (CFS/FM). We aimed to determine the interactions between genetic and epigenetic mechanisms regulating COMT and its influence on inflammatory markers and symptoms in patients with CFS/FM. Methods. A case-control study with repeated-measures design was used to reduce the chance of false positive and increase the power of our findings. Fifty-four participants (28 patients with CFS/FM and 26 controls) were assessed twice within 4 days. The assessment included clinical questionnaires, neurophysiological assessment (pain thresholds, temporal summation, and conditioned pain modulation), and blood withdrawal in order to assess rs4818, rs4633, and rs4680 COMT polymorphisms and perform haplotype estimation, DNA methylation in the COMT gene (both MB-COMT and S-COMT promoters), and cytokine expression (TNF-α, IFN-γ, IL-6, and TGF-β). Results. COMT haplotypes were associated with DNA methylation in the S-COMT promoter, TGF-β expression, and symptoms. However, this was not specific for one condition. Significant between-group differences were found for increased DNA methylation in the MB-COMT promoter and decreased IFN-γ expression in patients. DISCUSSION: Our results are consistent with basic and clinical research, providing interesting insights into genetic-epigenetic regulatory mechanisms. MB-COMT DNA methylation might be an independent factor contributing to the pathophysiology of CFS/FM. Further research on DNA methylation in complex conditions such as CFS/FM is warranted. We recommend future research to employ a repeated-measure design to control for biomarkers variability and within-subject changes. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12967-022-03662-7. |
format | Online Article Text |
id | pubmed-9598022 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-95980222022-10-27 Genetic and epigenetic regulation of Catechol-O-methyltransferase in relation to inflammation in chronic fatigue syndrome and Fibromyalgia Polli, Andrea Hendrix, Jolien Ickmans, Kelly Bakusic, Jelena Ghosh, Manosij Monteyne, Dora Velkeniers, Brigitte Bekaert, Bram Nijs, Jo Godderis, Lode J Transl Med Research BACKGROUND: Catechol-O-methyltransferase (COMT) has been shown to influence clinical pain, descending modulation, and exercise-induced symptom worsening. COMT regulates nociceptive processing and inflammation, key pathophysiological features of Chronic Fatigue Syndrome and Fibromyalgia (CFS/FM). We aimed to determine the interactions between genetic and epigenetic mechanisms regulating COMT and its influence on inflammatory markers and symptoms in patients with CFS/FM. Methods. A case-control study with repeated-measures design was used to reduce the chance of false positive and increase the power of our findings. Fifty-four participants (28 patients with CFS/FM and 26 controls) were assessed twice within 4 days. The assessment included clinical questionnaires, neurophysiological assessment (pain thresholds, temporal summation, and conditioned pain modulation), and blood withdrawal in order to assess rs4818, rs4633, and rs4680 COMT polymorphisms and perform haplotype estimation, DNA methylation in the COMT gene (both MB-COMT and S-COMT promoters), and cytokine expression (TNF-α, IFN-γ, IL-6, and TGF-β). Results. COMT haplotypes were associated with DNA methylation in the S-COMT promoter, TGF-β expression, and symptoms. However, this was not specific for one condition. Significant between-group differences were found for increased DNA methylation in the MB-COMT promoter and decreased IFN-γ expression in patients. DISCUSSION: Our results are consistent with basic and clinical research, providing interesting insights into genetic-epigenetic regulatory mechanisms. MB-COMT DNA methylation might be an independent factor contributing to the pathophysiology of CFS/FM. Further research on DNA methylation in complex conditions such as CFS/FM is warranted. We recommend future research to employ a repeated-measure design to control for biomarkers variability and within-subject changes. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12967-022-03662-7. BioMed Central 2022-10-25 /pmc/articles/PMC9598022/ /pubmed/36284330 http://dx.doi.org/10.1186/s12967-022-03662-7 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Polli, Andrea Hendrix, Jolien Ickmans, Kelly Bakusic, Jelena Ghosh, Manosij Monteyne, Dora Velkeniers, Brigitte Bekaert, Bram Nijs, Jo Godderis, Lode Genetic and epigenetic regulation of Catechol-O-methyltransferase in relation to inflammation in chronic fatigue syndrome and Fibromyalgia |
title | Genetic and epigenetic regulation of Catechol-O-methyltransferase in relation to inflammation in chronic fatigue syndrome and Fibromyalgia |
title_full | Genetic and epigenetic regulation of Catechol-O-methyltransferase in relation to inflammation in chronic fatigue syndrome and Fibromyalgia |
title_fullStr | Genetic and epigenetic regulation of Catechol-O-methyltransferase in relation to inflammation in chronic fatigue syndrome and Fibromyalgia |
title_full_unstemmed | Genetic and epigenetic regulation of Catechol-O-methyltransferase in relation to inflammation in chronic fatigue syndrome and Fibromyalgia |
title_short | Genetic and epigenetic regulation of Catechol-O-methyltransferase in relation to inflammation in chronic fatigue syndrome and Fibromyalgia |
title_sort | genetic and epigenetic regulation of catechol-o-methyltransferase in relation to inflammation in chronic fatigue syndrome and fibromyalgia |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9598022/ https://www.ncbi.nlm.nih.gov/pubmed/36284330 http://dx.doi.org/10.1186/s12967-022-03662-7 |
work_keys_str_mv | AT polliandrea geneticandepigeneticregulationofcatecholomethyltransferaseinrelationtoinflammationinchronicfatiguesyndromeandfibromyalgia AT hendrixjolien geneticandepigeneticregulationofcatecholomethyltransferaseinrelationtoinflammationinchronicfatiguesyndromeandfibromyalgia AT ickmanskelly geneticandepigeneticregulationofcatecholomethyltransferaseinrelationtoinflammationinchronicfatiguesyndromeandfibromyalgia AT bakusicjelena geneticandepigeneticregulationofcatecholomethyltransferaseinrelationtoinflammationinchronicfatiguesyndromeandfibromyalgia AT ghoshmanosij geneticandepigeneticregulationofcatecholomethyltransferaseinrelationtoinflammationinchronicfatiguesyndromeandfibromyalgia AT monteynedora geneticandepigeneticregulationofcatecholomethyltransferaseinrelationtoinflammationinchronicfatiguesyndromeandfibromyalgia AT velkeniersbrigitte geneticandepigeneticregulationofcatecholomethyltransferaseinrelationtoinflammationinchronicfatiguesyndromeandfibromyalgia AT bekaertbram geneticandepigeneticregulationofcatecholomethyltransferaseinrelationtoinflammationinchronicfatiguesyndromeandfibromyalgia AT nijsjo geneticandepigeneticregulationofcatecholomethyltransferaseinrelationtoinflammationinchronicfatiguesyndromeandfibromyalgia AT godderislode geneticandepigeneticregulationofcatecholomethyltransferaseinrelationtoinflammationinchronicfatiguesyndromeandfibromyalgia |